OPTN
Income statement / Annual
Last year (2023), OptiNose, Inc.'s total revenue was $70.99 M,
a decrease of 6.93% from the previous year.
In 2023, OptiNose, Inc.'s net income was -$35.48 M.
See OptiNose, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
$70.99 M |
$76.28 M |
$74.65 M |
$49.12 M |
$34.63 M |
$7.07 M |
$0.00 |
$47.50 M |
$85,000.00 |
Cost of Revenue |
$8.63 M
|
$9.26 M
|
$9.15 M
|
$7.52 M
|
$5.29 M
|
$1.59 M
|
$164,000.00
|
$0.00
|
$0.00
|
Gross Profit |
$62.35 M
|
$67.01 M
|
$65.50 M
|
$41.60 M
|
$29.34 M
|
$5.48 M
|
-$164,000.00
|
$47.50 M
|
$85,000.00
|
Gross Profit Ratio |
0.88
|
0.88
|
0.88
|
0.85
|
0.85
|
0.78
|
0
|
1
|
1
|
Research and Development Expenses |
$5.30 M
|
$15.26 M
|
$25.32 M
|
$23.38 M
|
$20.78 M
|
$10.10 M
|
$16.83 M
|
$15.31 M
|
$22.16 M
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$95.62 M
|
$31.70 M
|
$0.00
|
$0.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$79.80 M
|
$107.65 M
|
$106.63 M
|
$105.44 M
|
$104.16 M
|
$95.62 M
|
$31.70 M
|
$6.87 M
|
$6.01 M
|
Other Expenses |
$0.00
|
-$18.94 M
|
-$15.85 M
|
-$12.57 M
|
-$14.45 M
|
-$6.42 M
|
-$372,000.00
|
$0.00
|
$0.00
|
Operating Expenses |
$85.10 M
|
$122.91 M
|
$131.95 M
|
$128.82 M
|
$124.94 M
|
$105.72 M
|
$48.53 M
|
$21.45 M
|
$27.52 M
|
Cost And Expenses |
$93.74 M
|
$132.17 M
|
$141.10 M
|
$136.34 M
|
$130.23 M
|
$107.31 M
|
$48.53 M
|
$21.45 M
|
$27.52 M
|
Interest Income |
$2.53 M
|
$513,000.00
|
$52,000.00
|
$426,000.00
|
$2.36 M
|
$2.45 M
|
$303,000.00
|
$143,000.00
|
$28,000.00
|
Interest Expense |
$19.53 M
|
$16.84 M
|
$15.97 M
|
$13.01 M
|
$9.62 M
|
$9.23 M
|
$910,000.00
|
$3.52 M
|
$819,000.00
|
Depreciation & Amortization |
$402,000.00
|
$532,000.00
|
$645,000.00
|
$1.45 M
|
$1.11 M
|
$535,000.00
|
$164,000.00
|
$83,000.00
|
$75,000.00
|
EBITDA |
-$15.55 M |
-$57.46 M |
-$65.68 M |
-$85.32 M |
-$99.32 M |
-$96.89 M |
-$48.36 M |
$25.40 M |
-$27.42 M |
EBITDA Ratio |
-0.22
|
-0.73
|
-0.89
|
-1.78
|
-2.76
|
-14.19
|
0
|
0.55
|
-321.54
|
Operating Income Ratio |
-0.32
|
-0.73
|
-0.89
|
-1.78
|
-2.76
|
-14.19
|
0
|
0.53
|
-330.32
|
Total Other Income/Expenses Net |
-$12.74 M
|
-$18.94 M
|
-$15.85 M
|
-$12.57 M
|
-$14.45 M
|
-$6.42 M
|
-$372,000.00
|
-$2.71 M
|
-$237,000.00
|
Income Before Tax |
-$35.48 M
|
-$74.83 M
|
-$82.30 M
|
-$99.79 M
|
-$110.05 M
|
-$106.66 M
|
-$48.90 M
|
$22.61 M
|
-$28.31 M
|
Income Before Tax Ratio |
-0.5
|
-0.98
|
-1.1
|
-2.03
|
-3.18
|
-15.1
|
0
|
0.48
|
-333.11
|
Income Tax Expense |
$0.00
|
$1.56 M
|
-$646,000.00
|
-$1.46 M
|
-$1.11 M
|
$2.81 M
|
-$164,000.00
|
$3.52 M
|
$819,000.00
|
Net Income |
-$35.48 M
|
-$76.40 M
|
-$81.65 M
|
-$98.33 M
|
-$108.95 M
|
-$106.66 M
|
-$48.90 M
|
$22.61 M
|
-$28.31 M
|
Net Income Ratio |
-0.5
|
-1
|
-1.09
|
-2
|
-3.15
|
-15.1
|
0
|
0.48
|
-333.11
|
EPS |
-0.32 |
-0.89 |
-1.44 |
-2.04 |
-2.6 |
-2.68 |
-4.45 |
0.36 |
-1.06 |
EPS Diluted |
-0.32 |
-0.89 |
-1.44 |
-2.04 |
-2.6 |
-2.68 |
-4.45 |
0.0604 |
-1.06 |
Weighted Average Shares Out |
$112.08 M
|
$85.90 M
|
$56.85 M
|
$48.28 M
|
$41.88 M
|
$39.77 M
|
$11.00 M
|
$26.72 M
|
$26.72 M
|
Weighted Average Shares Out Diluted |
$112.08 M
|
$85.90 M
|
$56.85 M
|
$48.28 M
|
$41.88 M
|
$39.77 M
|
$11.00 M
|
$26.72 M
|
$26.72 M
|
Link |
|
|
|
|
|
|
|
|
|